Clinical Trial

Pregnancy Screening for Women on Opioid Substitution Therapy

Study Description

Routine Pregnancy Screening for Women on Opioid Substitution Therapy

Women who take opioid substitution therapy have higher rates of unintended pregnancy, more pregnancies, and a higher risk of pregnancy complications than the general population. Current practice is to test for pregnancy only at patient request or if the clinician suspects pregnancy. This study will compare monthly pregnancy testing to current practice in a double blind randomized control trial. As many women of childbearing age as possible will be recruited from the Hamilton Clinic for Opioid Substitutional Therapy. Women assigned to the intervention will have monthly testing at the same time as their monthly urine drug testing at the clinic. The primary objective is to assess if there is a significant difference is early pregnancy detection and the secondary objectives are to assess differences in pregnancy disposition and gestational age at entry to prenatal or abortion care.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Monthly Pregnancy Screening

Pregnancy test will be administered once per month during weekly urine testing for drug levels.

Usual Care

Usual care.

Additional Information

Official Study Title

Routine Pregnancy Screening for Women on Opioid Substitution Therapy: A Randomized Controlled Trial

Clinical Trial ID

NCT03489174

ParticipAid ID

Rb4lJb